Home » Topics » BioWorld

BioWorld
RSS

AMVAX VACCINE DEAL WITH ROCKEFELLER U.

March 30, 1992

JAPANESE STOCK DIP TRIGGERS SELL-OFF

March 30, 1992

SPINOFF TARGETS CELL-BASED THERAPIES

March 30, 1992

SHAREHOLDER SUIT CHALLENGES IVAX DEAL

March 30, 1992

APPOINTMENTS AND ADVANCEMENTS

March 30, 1992

QUIDEL TRADES TECHNOLOGY WITH BECTON

March 27, 1992

SYNGENE COUNTERSUES GEN-PROBE

March 27, 1992

STEM CELL TRIALS IN BREAST CANCER

March 27, 1992

ANTIBODIES DERIVED FROM MACAQUE MONKEYS

March 27, 1992

BIGGEST BIOTECH START-UP RAISES $46M

March 27, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...